Evidence map›Paper›PMID 34094796›Full record

ArticleEuropean physical journal plus2021

Application of reinforcement learning for effective vaccination strategies of coronavirus disease 2019 (COVID-19).

Alireza Beigi, Amin Yousefpour, Amirreza Yasami, J F Gómez-Aguilar, Stelios Bekiros, Hadi Jahanshahi

Abstract read
In one paragraph

Article in European physical journal plus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alireza BeigiSchool of Mechanical Engineering, College of Engineering, University of Tehran, 14399‒57131 Tehran, Iran.
Amin YousefpourSchool of Mechanical Engineering, College of Engineering, University of Tehran, 14399‒57131 Tehran, Iran.
Amirreza YasamiSchool of Mechanical Engineering, College of Engineering, University of Tehran, 14399‒57131 Tehran, Iran.
J F Gómez-AguilarCONACyT-Tecnológico Nacional de México/CENIDET, Interior Internado Palmira S/N, Col. Palmira, C.P. 62490 Cuernavaca, Morelos Mexico.ORCID 0000-0001-9403-3767
Stelios BekirosDepartment of Banking and Finance, FEMA, , University of Malta, Msida, MSD 2080 Malta.
Hadi JahanshahiDepartment of Mechanical Engineering, University of Manitoba, Winnipeg, R3T 5V6 Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since December 2019, the new coronavirus has raged in China and subsequently all over the world. From the first days, researchers have tried to discover vaccines to combat the epidemic. Several vaccines are now available as a result of the contributions of those researchers. As a matter of fact, the available vaccines should be used in effective and efficient manners to put the pandemic to an end. Hence, a major problem now is how to efficiently distribute these available vaccines among various components of the population. Using mathematical modeling and reinforcement learning control approaches, the present article aims to address this issue. To this end, a deterministic Susceptible-Exposed-Infectious-Recovered-type model with additional vaccine components is proposed. The proposed mathematical model can be used to simulate the consequences of vaccination policies. Then, the suppression of the outbreak is taken to account. The main objective is to reduce the effects of Covid-19 and its domino effects which stem from its spreading and progression. Therefore, to reach optimal policies, reinforcement learning optimal control is implemented, and four different optimal strategies are extracted. Demonstrating the efficacy of the proposed methods, finally, numerical simulations are presented.

Identifiers

PMID34094796
PMCPMC8166378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.